Induction of bovine articular chondrocyte senescence with oxidized low-density lipoprotein through lectin-like oxidized low-density lipoprotein receptor 1

Arthritis and Rheumatism

Volumn 60, Issue 10, 2009, Pages 3007-3016

  Zushi, Satoshi ^a   Akagi, Masao ^a   Kishimoto, Hideki ^a   Teramura, Takeshi ^a   Sawamura, Tatsuya ^b   Hamanishi, Chiaki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AGGRECAN; BETA GALACTOSIDASE; BROXURIDINE; COLLAGEN TYPE 2; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; TELOMERASE; TS 20 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL AGING; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; COW; ENZYME ACTIVITY; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BETA-GALACTOSIDASE; CARTILAGE, ARTICULAR; CATTLE; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CHROMONES; ENZYME INHIBITORS; FEMALE; LIPOPROTEINS, LDL; MODELS, ANIMAL; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SCAVENGER RECEPTORS, CLASS E; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 70349758283     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24816     Document Type: Article

References (55)

1. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792
2. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997;386:73-77 (Pubitemid 27130922)
3. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006; 69:36-45. (Pubitemid 41814809)
4. Stockwell RA. Lipid in the matrix of ageing articular cartilage. Nature 1965;207:427-428
5. Lippiello L. The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 1991;40:571-576
6. Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation: possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 2000;30:20069-20076 (Pubitemid 30441616)
7. Shah R, Raska K Jr, Tiku ML. The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: a pathogenic role in osteoarthritis. Arthritis Rheum 2005;52:2799-2807 (Pubitemid 41369109)
8. Hart DJ, Doyle DV, Spector TD. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 1995;22:1118-1123
9. McAlindon TE, Jacques P, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39:648-656
10. Nakagawa T, Akagi M, Hoshikawa H, Chen M, Yasuda T, Mukai S, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis. Arthritis Rheum 2002;46: 2486-2494
11. Nakagawa T, Yasuda T, Hoshikawa H, Shimizu M, Kakinuma T, Chen M, et al. LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death: possible role of dephosphorylation of Akt. Biochem Biophys Res Commun 2002;229: 91-97 (Pubitemid 35366039)
12. Nishimura S, Akagi M, Yoshida K, Hayakawa S, Sawamura T, Munakata H, et al. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-κB. Osteoarthritis Cartilage 2004;12:568-576 (Pubitemid 38950267)
13. Akagi M, Ueda A, Teramura T, Kanata S, Sawamura T, Hamanishi C. Oxidized LDL binding to LOX-1 enhances MCP-1 expression in cultured human articular chondrocytes. Osteoarthritis Cartilage 2009;17:271-275
14. Kakinuma T, Yasuda T, Nakagawa T, Hiramitsu T, Akiyoshi M, Akagi M, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage. Arthritis Rheum 2004;50:3495-3503 (Pubitemid 39488674)
15. Akagi M, Kanata S, Mori S, Itabe H, Sawamura T, Hamanishi C. Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis. Osteoarthritis Cartilage 2007;15:281-290 (Pubitemid 46238241)
16. Simopoulou T, Malizos KN, Tsezou A. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes. Clin Exp Rheumatol 2007;25:605-612 (Pubitemid 47455469)
17. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I. Aging arteries: a "set up" for vascular disease. Circulation 2003;107:139-146
18. Felson DT. Epidemiology of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, editors. Osteoarthritis. Oxford: Oxford University Press; 1998. p. 13-22.
19. Buckwalter JA, Martin J, Mankin HJ. Synovial joint degeneration and the syndrome of osteoarthritis. Instr Course Lect 2000;49: 481-489
20. Erusalimsky JD, Kurz DJ. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol 2005; 40:634-642
21. Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res 2007;100:15-26. (Pubitemid 46074968)
22. Martin JA, Buckwalter JA. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am 2003;85 Suppl 2:106-110
23. Price JS, Waters JG, Darrah C, Pennington C, Edwards DR, Donell ST, et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 2002;1:57-65.
24. Martin JA, Klingelhutz AJ, Moussavi-Harami F, Buckwalter JA. Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J Gerontol A Biol Sci Med Sci 2004;59:324-337 (Pubitemid 38478730)
25. Yudoh K, Nguyen T, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005;7:R380-91.
26. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460 (Pubitemid 20178256)
27. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992;89:10114-10118
28. Bryan TM, Cech TR. Telomerase and the maintenance of chromosome ends. Curr Opin Cell Biol 1999;11:318-324
29. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol 2000;18:2626-2634 (Pubitemid 30432531)
30. Minamino T, Mitsialis SA, Kourembanas S. Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 2001;21:3336-3342 (Pubitemid 32381769)
31. Martin JA, Buckwalter JA. Telomere erosion and senescence in human articular cartilage chondrocytes. J Gerontol A Biol Sci Med Sci 2001;56:B172-9.
32. Martin JA, Buckwalter JA. Human chondrocyte senescence and osteoarthritis. Biorheology 2002;39:145-152
33. Piera-Velazquez S, Jimenez SA, Stokes DG. Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase. Arthritis Rheum 2002;46:683-693 (Pubitemid 34214251)
34. Chen J, Goligorsky MS. Premature senescence of endothelial cells: Methusaleh's dilemma. Am J Physiol Heart Circ Physiol 2006;290: H1729-39.
35. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-976 (Pubitemid 40311739)
36. Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 2001;493:21-25 (Pubitemid 32241169)
37. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis: an introduction: cell biology of osteoarthritis [review]. Arthritis Res 2001;3:107-113 (Pubitemid 32237037)
38. Aubrey JH. Pathology of osteoarthritis. In: Moskowitz RW, Altman RD, Hochberg MC, Buckwalter JA, Goldberg VM, editors. Osteoarthritis. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 51-72.
39. Sandell LJ, Heinegard D, Herring TM. Cell biology, biochemistry, and molecular biology of articular cartilage in osteoarthritis. In: Moskowitz RW, Altman RD, Hochberg MC, Buckwalter JA, Goldberg VM, editors. Osteoarthritis. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 73-106.
40. Buckwalter JA, Mankin HJ, Grodzinsky AJ. Articular cartilage and osteoarthritis. Instr Course Lect 2005;54:465-479
41. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995;92:9363-9367
42. Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004;31: 407-413 (Pubitemid 39044118)
43. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015
44. Osanai M, Tamaki T, Yonekawa M, Kawamura A, Sawada N. Transient increase in telomerase activity of proliferating fibroblasts and endothelial cells in granulation tissue of the human skin. Wound Repair Regen 2002;10:59-66. (Pubitemid 34496482)
45. Wege H, Brummendorf TH. Telomerase activation in liver regeneration and hepatocarcinogenesis: Dr. Jekyll or Mr. Hyde? Curr Stem Cell Res Ther 2007;2:31-38
46. Parsch D, Fellenberg J, Brummendorf TH, Eschlbeck AM, Richter W. Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med 2004;82:49-55. (Pubitemid 38168101)
47. Parsch D, Brummendorf TH, Richter W, Fellenberg J. Replicative aging of human articular chondrocytes during ex vivo expansion. Arthritis Rheum 2002;46:2911-2916 (Pubitemid 35315882)
48. Broccoli D, Young JW, Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995;92:9082-9086
49. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003;114:241-253 (Pubitemid 36936917)
50. Liu JP. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 1999;13:2091-2104
51. Jeong SJ, Dasgupta A, Jung KJ, Um JH, Burke A, Park HU, et al. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 2008;370:264-272 (Pubitemid 350199679)
52. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999;13:2905-2927
53. Oh CD, Chun JS. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. J Biol Chem 2003;278:36563-36571
54. Starkman BG, Cravero JD, Delcarlo M, Loeser RF. IGF-1 stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochem J 2005;389:723-729
55. Yuan XM, Li W, Dalen H, Lotem J, Kama R, Sachs L, et al. Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci U S A 2002;99:6286-6291